Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen

Preclinical models and clinical studies have shown that anti-CD20-based treatment has multifaceted consequences on T-cell immunity. We have performed a prospective study of peripheral T-cell compartment in FL patients, all exhibiting high tumor burden and receiving rituximab-chemotherapy-based regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Milcent, B., Josseaume, N., Petitprez, F., Riller, Q., Amorim, S., Loiseau, P., Toubert, A., Brice, P., Thieblemont, C., Teillaud, J.-L., Sibéril, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748924/
https://www.ncbi.nlm.nih.gov/pubmed/31530876
http://dx.doi.org/10.1038/s41598-019-50029-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748924/
https://www.ncbi.nlm.nih.gov/pubmed/31530876
http://dx.doi.org/10.1038/s41598-019-50029-y

Ejemplares similares